Roth Conference Archives - Page 67 of 117

MondayMar 12, 2018 5:00 pm

Farmer Brothers Co. (NASDAQ: FARM) Starts Presentation at 30th Annual ROTH Conference

Farmer Bros. (NASDAQ: FARM) is a national coffee roaster, wholesaler and distributor of coffee, tea and culinary products. The company’s product lines include organic, direct trade and sustainably-produced coffee. With a robust line of coffee, hot and iced teas, cappuccino mixes, spices, and baking/biscuit mixes, the company delivers extensive beverage planning services and culinary products to its U.S.-based customers. The company serves a wide variety of customers, from small independent restaurants and foodservice operators to large institutional buyers like restaurant and convenience store chains, hotels, casinos, hospitals and gourmet coffee houses, as well as grocery chains with private brand coffee…

MondayMar 12, 2018 5:00 pm

Blue Bird Corp. (NASDAQ: BLBD) Starts Presentation at 30th Annual ROTH Conference

Blue Bird (NASDAQ: BLBD) is an independent designer and manufacturer of school buses, with more than 550,000 buses sold since its formation in 1927 and approximately 180,000 buses in operation today. Blue Bird focuses on the design, engineering, manufacture and sale of school buses and related parts. The company is the only manufacturer of chassis and body production specifically designed for school bus applications, and offers alternative fuel applications with its propane-powered and compressed natural gas-powered school buses. Blue Bird manufactures school buses at two facilities in Fort Valley, Georgia. Its Micro Bird joint venture operates a manufacturing facility in…

MondayMar 12, 2018 5:00 pm

Daré Bioscience, Inc. (NASDAQ: DARE) Starts Presentation at 30th Annual ROTH Conference

Daré Bioscience (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s reproductive health. Daré currently has two product candidates in clinical development. The first is Ovaprene™, a non-hormonal monthly contraceptive ring intended to provide protection over multiple weeks between menses. The second is SST-6007 a potential treatment for Female Sexual Arousal Disorder. SST-6007 incorporates sildenafil, the same active ingredient in Viagra®, in a proprietary cream formulation that is specifically designed to locally increase blood flow to the vulvar-vaginal tissue in women, leading to a potential improvement in genital arousal response and overall sexual…

MondayMar 12, 2018 5:00 pm

Cypress Semiconductor Corp. (NYSE: CY) Starts Presentation at 30th Annual ROTH Conference

Cypress Semiconductor (NYSE: CY) is an international provider of advanced embedded system solutions for innovative automotive, industrial, smart home appliances, consumer electronics and medical products. The company’s microcontrollers, analog ICs, wireless and USB-based connectivity solutions and reliable, high-performance memories help engineers design differentiated products and bring them to market quickly. Cypress is committed to providing customers with the quality support and development resources which enables them to disrupt markets by creating new product categories in record time. For more information, visit the company’s website at www.cypress.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides…

MondayMar 12, 2018 4:30 pm

TransAct Technologies, Inc. (NASDAQ: TACT) Starts Presentation at 30th Annual ROTH Conference

TransAct Technologies (NASDAQ: TACT) develops software-driven technology and printing solutions for high-growth markets such as restaurant solutions, POS automation, casino and gaming, lottery, mobile, and oil and gas. TransAct’s solutions are created from the ground up based on customer requirements and are sold under the AccuDate™, EPICENTRAL®, Epic®, Ithaca®, RESPONDER and Printrex® brands. The company has installed more than 3 million printers and terminals throughout the world and is dedicated to offering world-class service, spare parts and accessories to support its installed product base. Additionally, the company offers a full range of supplies and consumable items, both online and through…

MondayMar 12, 2018 4:30 pm

Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) Starts Presentation at 30th Annual ROTH Conference

Ligand Pharmaceuticals (NASDAQ: LGND) is focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. The company’s Captisol® platform technology is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. OmniAb® is a patent-protected transgenic animal platform used in the discovery of fully human mono- and bispecific therapeutic antibodies. The company partners with other pharmaceutical companies to ultimately generate further revenue. Such alliances, licenses and other business relationships include Novartis, Amgen, Merck, Pfizer, Celgene, Gilead, Janssen, Baxter International and Eli Lilly. For more information, visit the company’s website…

MondayMar 12, 2018 4:30 pm

Layne Christensen Co. (NASDAQ: LAYN) Starts Presentation at 30th Annual ROTH Conference

Layne Christensen (NASDAQ: LAYN) is a global water management, construction, and drilling company that provides responsible solutions for water, mineral and energy challenges. The Woodlands, Texas-based company operates throughout North America, Africa, Australia, Europe, Brazil, and in other South American countries through its affiliates. Layne solutions comprise of identifying and developing a new water source, delivering usable water to communities and facilities around the world, recycling water from oil and gas resources, rehabilitating an existing pipeline, or safely returning wastewater to the natural environment. For more information, visit the company’s website at www.layne.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial…

MondayMar 12, 2018 4:30 pm

DMC Global, Inc. (NASDAQ: BOOM) Starts Presentation at 30th Annual ROTH Conference

DMC Global (NASDAQ: BOOM) operates in two sectors: industrial infrastructure and oilfield products and services. The industrial infrastructure sector is served by DMC’s NobelClad business, the world’s largest manufacturer of explosion-welded clad metal plates, which are used to fabricate capital equipment utilized within various process industries and other industrial sectors. The oilfield products and services sector is served by DynaEnergetics, an international developer, manufacturer and marketer of advanced explosive components and systems used to perforate oil and gas wells. For more information, visit the company’s website at www.dmcglobal.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company…

MondayMar 12, 2018 4:30 pm

The Ultimate Software Group, Inc. (NASDAQ: ULTI) Starts Presentation at 30th Annual ROTH Conference

The Ultimate Software Group (NASDAQ: ULTI) provides human capital management (HCM) solutions in the cloud and has more than 37 million people records in the Ultimate cloud. The company’s award-winning UltiPro provides HR, payroll, talent, and time and labor management solutions that connect people with the information they need to work more effectively. Ultimate has been the recipient of many prestigious awards, including being ranked No. 3 by Fortune for 2018 on its “100 Best Companies to Work For” and No. 1 in the Large Company category on its “40 Best Workplaces in Technology” list. The company serves more than…

MondayMar 12, 2018 4:30 pm

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) Starts Presentation at 30th Annual ROTH Conference

Sorrento Therapeutics (NASDAQ: SRNE) is a clinical-stage, antibody-centric, biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possibly curable diseases. Sorrento’s multimodal multipronged approach to fighting cancer is made possible by its’ extensive immuno-oncology platforms, including key assets such as fully human antibodies (“G-MAB™ library”), clinical stage immuno-cellular therapies (“CAR-T”), intracellular targeting antibodies (“iTAbs”), antibody-drug conjugates (“ADC”), and clinical stage oncolytic virus (“Sephrevir®”). Sorrento’s commitment to life-enhancing therapies for cancer patients is also demonstrated by our effort to advance a first-in-class (TRPV1 agonist) non-opioid pain management small molecule in Resiniferatoxin (“RTX”) and ZTlido. Resiniferatoxin is completing a…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Category: Roth Conference

Farmer Brothers Co. (NASDAQ: FARM) Starts Presentation at 30th Annual ROTH Conference

Blue Bird Corp. (NASDAQ: BLBD) Starts Presentation at 30th Annual ROTH Conference

Daré Bioscience, Inc. (NASDAQ: DARE) Starts Presentation at 30th Annual ROTH Conference

Cypress Semiconductor Corp. (NYSE: CY) Starts Presentation at 30th Annual ROTH Conference

TransAct Technologies, Inc. (NASDAQ: TACT) Starts Presentation at 30th Annual ROTH Conference

Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) Starts Presentation at 30th Annual ROTH Conference

Layne Christensen Co. (NASDAQ: LAYN) Starts Presentation at 30th Annual ROTH Conference

DMC Global, Inc. (NASDAQ: BOOM) Starts Presentation at 30th Annual ROTH Conference

The Ultimate Software Group, Inc. (NASDAQ: ULTI) Starts Presentation at 30th Annual ROTH Conference

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) Starts Presentation at 30th Annual ROTH Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search